Therefore, these results provide strong evidence, independent of Wnt antagonists, that constitutive activation of Wnt signaling involved an autocrine Wnt loop, and implicated LRP6 as the specific Wnt canonical co-receptor involved in bone sarcomas. The gene discussed is LRP6; the disease is bone sarcoma.